Agile Therapeutics, Inc. (AGRX) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 9 Buy, 1 Hold.
The consensus price target is $1.00, representing a downside of 33.8% from the current price $1.51.
AGRX Stock — 12-Month Price Forecast
$1.00
▼ -33.77% Downside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Agile Therapeutics, Inc., the price target is $1.00.
The average price target represents a -33.77% change from the last price of $1.51.
AGRX Analyst Ratings
Buy
Based on 10 analysts giving stock ratings to Agile Therapeutics, Inc. in the past 3 months
